Literature DB >> 7992668

Chronic and acute pain syndromes in patients with multiple sclerosis.

A Indaco1, C Iachetta, C Nappi, L Socci, P B Carrieri.   

Abstract

We have studied 122 patients (52 men and 70 women) with definite Multiple Sclerosis (MS) to evaluate the frequency and clinical characteristics of pain in MS. The Hamilton Rating Scale for depression, the Beck-Self Depression Inventory and the Kurtzke Disability Status Scale were used in all patients. We have divided the patients with pain in two groups: patients with pain syndromes at onset and patients with pain syndromes during the course of MS disease. We found that 57% of all our MS patients complained of pain syndromes at some time during the MS course, while 21% reported pain as a symptom at onset of MS. The majority of patients suffered from chronic pain (constant or intermittent pain lasting more than one month). The most frequent chronic syndromes were dysesthetic extremity pain, painful spasms and tonic seizures. We did not find a significant differences with respect to age, sex, disease duration, physical impairment, depressive symptoms between the patients of pain-free group and of pain groups. There was a significant difference in mean disease duration from diagnosis in patients reporting pain at onset of the disease. In conclusion, the pain in MS is not a rare symptom; the role of physiopathological mechanism underlying pain syndromes arise unclear.

Entities:  

Mesh:

Year:  1994        PMID: 7992668

Source DB:  PubMed          Journal:  Acta Neurol (Napoli)        ISSN: 0001-6276


  15 in total

1.  Rehabilitation challenges in multiple sclerosis.

Authors:  Jack S Burks; George Kim Bigley; Harry Haydon Hill
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

2.  CaMKIIα Mediates the Effect of IL-17 To Promote Ongoing Spontaneous and Evoked Pain in Multiple Sclerosis.

Authors:  Xiaoyu Hu; Fang Huang; Zaijie Jim Wang
Journal:  J Neurosci       Date:  2017-11-16       Impact factor: 6.167

Review 3.  Management of pain in multiple sclerosis: a pharmacological approach.

Authors:  Claudio Solaro; Michele Messmer Uccelli
Journal:  Nat Rev Neurol       Date:  2011-08-16       Impact factor: 42.937

4.  A comparison of self-hypnosis versus progressive muscle relaxation in patients with multiple sclerosis and chronic pain.

Authors:  Mark P Jensen; Joseph Barber; Joan M Romano; Ivan R Molton; Katherine A Raichle; Travis L Osborne; Joyce M Engel; Brenda L Stoelb; George H Kraft; David R Patterson
Journal:  Int J Clin Exp Hypn       Date:  2009-04

Review 5.  Pain and multiple sclerosis: pathophysiology and treatment.

Authors:  Claudio Solaro; Erika Trabucco; Michele Messmer Uccelli
Journal:  Curr Neurol Neurosci Rep       Date:  2013-01       Impact factor: 5.081

6.  Decreased spinal cord opioid receptor mRNA expression and antinociception in a Theiler's murine encephalomyelitis virus model of multiple sclerosis.

Authors:  Jessica L Lynch; Jeremy F Alley; Lori Wellman; Alvin J Beitz
Journal:  Brain Res       Date:  2007-11-28       Impact factor: 3.252

7.  Prevalence and impact of pain in multiple sclerosis: physical and psychologic contributors.

Authors:  Adam T Hirsh; Aaron P Turner; Dawn M Ehde; Jodie K Haselkorn
Journal:  Arch Phys Med Rehabil       Date:  2009-04       Impact factor: 3.966

Review 8.  Temperature sensitivity in multiple sclerosis: An overview of its impact on sensory and cognitive symptoms.

Authors:  Aikaterini Christogianni; Richard Bibb; Scott L Davis; Ollie Jay; Michael Barnett; Nikos Evangelou; Davide Filingeri
Journal:  Temperature (Austin)       Date:  2018-09-05

9.  Willingness to pay for a treatment for pain in multiple sclerosis.

Authors:  Michael Iskedjian; Olivier Desjardins; Charles Piwko; Basil Bereza; Barbara Jaszewski; Thomas R Einarson
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

10.  Pain due to multiple sclerosis: analysis of the prevalence and economic burden in Canada.

Authors:  Charles Piwko; Olivier B Desjardins; Basil G Bereza; Marcio Machado; Barbara Jaszewski; Mark S Freedman; Thomas R Einarson; Michael Iskedjian
Journal:  Pain Res Manag       Date:  2007       Impact factor: 3.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.